Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival

Transplant Immunology - Tập 34 - Trang 1-7 - 2016
Dolores Redondo-Pachón1, Julio Pascual1, María J. Pérez-Sáez1, Carmen García2, Juan José Hernández2, Javier Gimeno3, Marisa Mir1, Marta Crespo1
1Department of Nephrology, Institute Mar for Medical Research, Hospital del Mar, Barcelona, Spain
2Laboratori de Referencia de Catalunya, Barcelona, Spain
3Department of Pathology, Hospital del Mar, Barcelona, Spain

Tài liệu tham khảo

Pei, 2003, Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities, Transplantation, 75, 43, 10.1097/00007890-200301150-00008 Mizutani, 2007, The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients, Am. J. Transplant., 7, 1027, 10.1111/j.1600-6143.2006.01721.x Tait, 2013, Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation, Transplantation, 95, 19, 10.1097/TP.0b013e31827a19cc Lefaucheur, 2010, Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J. Am. Soc. Nephrol., 21, 1398, 10.1681/ASN.2009101065 Gloor, 2010, Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation, Am. J. Transplant., 10, 582, 10.1111/j.1600-6143.2009.02985.x Wiebe, 2012, Evolution and clinical–pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am. J. Transplant., 12, 1157, 10.1111/j.1600-6143.2012.04013.x Loupy, 2012, The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nat. Rev. Nephrol., 8, 348, 10.1038/nrneph.2012.81 Everly, 2013, Incidence and impact of de novo donor-specific alloantibody in primary renal allografts, Transplantation, 91, 410, 10.1097/TP.0b013e31827d62e3 Gilbert, 2011, Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome, Transplant. Proc., 43, 3412, 10.1016/j.transproceed.2011.09.023 Versluis, 1993, High-resolution HLA-DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2, Hum. Immunol., 38, 277, 10.1016/0198-8859(93)90555-F Billen, 2010, HLA-DP antibodies before and after renal transplantation, Tissue Antigens, 75, 278, 10.1111/j.1399-0039.2009.01428.x Pfeiffer, 1995, HLA-DP antibodies in patients awaiting renal transplantation, Transpl. Int., 8, 180, 10.1111/j.1432-2277.1995.tb01500.x Youngs, 2004, HLA-DP alloantibodies, 60 Ling, 2012, Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients, Hum. Immunol., 73, 879, 10.1016/j.humimm.2012.07.320 Mytilineos, 1997, Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study, Transplantation, 63, 1351, 10.1097/00007890-199705150-00025 Qiu, 2005, Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads, Transplantation, 80, 1511, 10.1097/01.tp.0000181384.49832.3a Caro-Oleas, 2012, Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation, Transplantation, 94, 338, 10.1097/TP.0b013e31825ace2c Lachmann, 2009, Anti-human leukocyte antigen and donor-specific antibodies detected by Luminex posttransplant serve as biomarkers for chronic rejection of renal allografts, Transplantation, 87, 1505, 10.1097/TP.0b013e3181a44206 Crespo, 2013, Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?, Transpl. Immunol., 29, 28, 10.1016/j.trim.2013.07.002 Loupy, 2013, Complement-binding anti-HLA antibodies and kidney-allograft survival, N. Engl. J. Med., 369, 1215, 10.1056/NEJMoa1302506 DeVos, 2012, Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation, Kidney Int., 82, 598, 10.1038/ki.2012.190 Willicombe, 2012, De novo DQ donor specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy, Transplantation, 94, 172, 10.1097/TP.0b013e3182543950 Wiebe, 2013, Class II HLA epitope matching—a strategy to minimize de novo donor specific antibody development and improve outcomes, Am. J. Transplant., 13, 3114, 10.1111/ajt.12478 Jolly, 2012, Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation, Am. J. Transplant., 12, 2845, 10.1111/j.1600-6143.2012.04172.x Bachelet, 2015, Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation, Transplantation Goral, 2008, Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation, Nephrol. Dial. Transplant., 23, 390, 10.1093/ndt/gfm703 Thaunat, 2009, Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation, Transpl. Immunol., 20, 209, 10.1016/j.trim.2008.12.006 Singh, 2010, Acute humoral rejection in a zero mismatch deceased donor renal transplant due to an antibody to an HLA-DP alpha, Transplantation, 90, 220, 10.1097/TP.0b013e3181e1177d